Medpace Holdings ROE 2014-2024 | MEDP

Current and historical return on equity (ROE) values for Medpace Holdings (MEDP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Medpace Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-06-30 $0.34B $0.76B 55.15%
2024-03-31 $0.31B $0.67B 59.82%
2023-12-31 $0.28B $0.56B 64.03%
2023-09-30 $0.27B $0.47B 68.71%
2023-06-30 $0.27B $0.39B 73.00%
2023-03-31 $0.26B $0.35B 75.26%
2022-12-31 $0.25B $0.39B 60.34%
2022-09-30 $0.23B $0.35B 41.26%
2022-06-30 $0.21B $0.28B 30.52%
2022-03-31 $0.20B $0.61B 24.18%
2021-12-31 $0.18B $0.95B 20.44%
2021-09-30 $0.18B $0.90B 21.32%
2021-06-30 $0.17B $0.85B 21.03%
2021-03-31 $0.16B $0.86B 19.78%
2020-12-31 $0.14B $0.81B 18.86%
2020-09-30 $0.12B $0.79B 16.68%
2020-06-30 $0.11B $0.74B 14.89%
2020-03-31 $0.11B $0.72B 15.75%
2019-12-31 $0.10B $0.73B 14.83%
2019-09-30 $0.09B $0.69B 14.36%
2019-06-30 $0.09B $0.66B 14.32%
2019-03-31 $0.08B $0.62B 13.32%
2018-12-31 $0.07B $0.59B 13.26%
2018-09-30 $0.06B $0.56B 11.72%
2018-06-30 $0.05B $0.54B 10.07%
2018-03-31 $0.05B $0.51B 8.47%
2017-12-31 $0.04B $0.50B 6.84%
2017-09-30 $0.03B $0.55B 4.69%
2017-06-30 $0.02B $0.61B 3.76%
2017-03-31 $0.02B $0.62B 3.91%
2016-12-31 $0.01B $0.61B 4.26%
2016-06-30 $0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Services $11.839B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $118.753B 14.48
Cencora (COR) United States $45.072B 17.57
ICON (ICLR) Ireland $27.369B 24.59
DiDi Global (DIDIY) China $17.109B 0.00
Avantor (AVTR) United States $15.195B 22.37
CochLear (CHEOY) Australia $14.677B 0.00
Viatris (VTRS) United States $13.931B 4.16
Revvity (RVTY) United States $13.772B 24.16
Natera (NTRA) United States $13.029B 0.00
Charles River Laboratories (CRL) United States $11.456B 21.93
Solventum (SOLV) United States $10.033B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $9.918B 0.00
Sonic Healthcare (SKHHY) Australia $8.114B 0.00
HealthEquity (HQY) United States $6.801B 43.67
Bausch + Lomb (BLCO) Canada $5.689B 22.77
Organon (OGN) United States $5.563B 5.28
Doximity (DOCS) United States $5.170B 36.21
PACS (PACS) United States $5.142B 0.00
Life Times (LTH) United States $4.112B 43.08
Sotera Health (SHC) United States $3.787B 18.58
Surgery Partners (SGRY) United States $3.772B 34.51
GoodRx Holdings (GDRX) United States $3.366B 128.14
Agilon Health (AGL) United States $2.780B 0.00
Progyny (PGNY) United States $2.664B 45.87
AMN Healthcare Services Inc (AMN) United States $2.344B 9.29
Premier (PINC) United States $2.118B 9.06
BrightSpring Health Services (BTSG) United States $2.063B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.871B 0.00
Alignment Healthcare (ALHC) United States $1.776B 0.00
Teladoc Health (TDOC) United States $1.565B 0.00
Establishment Labs Holdings (ESTA) $1.315B 0.00
CareDx (CDNA) United States $0.959B 0.00
Embecta (EMBC) United States $0.943B 6.41
GeneDx Holdings (WGS) United States $0.884B 0.00
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.653B 0.00
Pediatrix Medical (MD) United States $0.646B 6.86
Sharecare (SHCR) United States $0.500B 0.00
Enhabit (EHAB) United States $0.498B 49.65
COMPASS Pathways (CMPS) United Kingdom $0.475B 0.00
Sonida Senior Living (SNDA) United States $0.446B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.331B 6.20
DocGo (DCGO) United States $0.330B 18.06
LifeMD (LFMD) United States $0.283B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.258B 0.00
Beauty Health (SKIN) United States $0.224B 0.00
Ascend Wellness Holdings (AAWH) United States $0.207B 0.00
Biodesix (BDSX) United States $0.187B 0.00
So-Young (SY) China $0.097B 47.00
Pono Capital Two (PTWO) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.043B 5.79
Oncology Institute (TOI) United States $0.042B 0.00
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.037B 0.00
Nutex Health (NUTX) United States $0.037B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.023B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.019B 0.00
TRxADE HEALTH (MEDS) United States $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
XWELL (XWEL) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
Aclarion (ACON) United States $0.003B 0.00